Who has invested in EyeD Pharma?

Fund+, Qbic II, Gilles Samyn, François Blondel, Denis Knoops are named among the investors backing EyeD Pharma.

EyeD Pharma Funding: $108M Raised, Series A (2021)

EyeD Pharma funding overview

EyeD Pharma is based in Liège, Belgium. EyeD Pharma has raised $108M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for EyeD Pharma runs through 2021; nothing later has been disclosed. Investors on record include Fund+, Qbic II, Gilles Samyn, François Blondel, Denis Knoops. 5 distinct backers are named across the disclosed rounds.

EyeD Pharma at a glance

Total raised: $108M
Latest round: Series A
Latest round date: May 2021
Headquarters: Liège, Belgium
Notable investors: Fund+, Qbic II, Gilles Samyn, François Blondel, Denis Knoops

Frequently asked about EyeD Pharma funding

How much has EyeD Pharma raised?: EyeD Pharma has raised $108M in total disclosed funding across the rounds on record.
Who has invested in EyeD Pharma?: Fund+, Qbic II, Gilles Samyn, François Blondel, Denis Knoops are named among the investors backing EyeD Pharma.
What was the latest EyeD Pharma funding round?: The most recent disclosed round is a Series A, announced in May 2021.
Where is EyeD Pharma based?: EyeD Pharma is based in Liège, Belgium.
When did EyeD Pharma last raise?: The last disclosed EyeD Pharma round closed in May 2021 at Series A.

EyeD Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Liège below to benchmark round size and investor mix.

EyeD Pharma Funding: $108M Raised, Series A (2021)

EyeD Pharma funding overview

EyeD Pharma at a glance

Frequently asked about EyeD Pharma funding

Companies related to EyeD Pharma (12)

Browse related funding lists (4)